NLS Collaboration

On May 24th, five Nordic university hospitals signed a Memorandum of Understanding (MoU) to inaugurate the new alliance, The Nordic University Hospital Alliance (NUHA). The goal is to strengthen relationships and collaborations between the hospitals and establish a strategy for addressing healthcare challenges in the Nordic region. The alliance aims to enhance quality and foster […]

The initiative will provide funding to maintain high-quality health databases in the country and to support research that uses this data to advance understanding of cardiometabolic diseases (CMD). The aim is to ensure that valuable data remains both secure and accessible for future research, strengthening the CMD research environment in Denmark, states Novo Nordisk Foundation […]

IRLAB Therapeutics has  announced a collaboration agreement with the McQuade Center for Strategic Research and Development (MSRD), a member of the global Otsuka family of pharmaceutical companies. IRLAB and MSRD will exclusively collaborate in the development of IRLAB’s novel drug candidate IRL757 for the potential treatment of apathy in Parkinson’s and other neurological conditions through […]

EIT Health Scandinavia has presented a hub that connects researchers, clinicians and industry with European biobanks and health data registries. The platform, EIT Health Biobanks and Health Data Registries, provides easy access to and exchange of information on European biobanks and health data registries which are crucial for promoting medical research and innovation, states EIT […]

In the beginning of March, Sahlgrenska Science Park, GoCo Health Innovation City, AstraZeneca, and other members of Health Innovation West invited participants, students, researchers, tech enthusiasts, life science experts, entrepreneurs, and others to a femtech innovation hackathon, a hackaton focused on reducing the gender health gap and advancing women’s health. Initiators of the hackaton were […]

The two companies have entered into an agreement regarding BAN2802, a potential new treatment combining BioArctic’s BrainTransporter technology with an undisclosed Alzheimer drug candidate. At the end of the collaboration, Eisai will evaluate the data generated and decide if they chose to exercise an option to license BAN2802 for the treatment of Alzheimer’s disease. “I […]